Ovary; Anomaly

2

Review clinical trials related to Ovary; Anomaly. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Autologous Platelet Rich Plasma Intraovarian Infusion for Poor Responders

Autologous platelet rich plasma (PRP) intraovarian infusion may improve ovarian response to controlled ovarian stimulation as well as the hormonal profile of poor ovarian response infertile women subjected to intracytoplasmic sperm injection (ICSI) treatment.

Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 35-47Biological sex: FemaleType: InterventionalSponsor: Genesis Athens ClinicUpdated: Dec 27, 2024Locations: 1
Eligibility criteria

Age ≥ 40 years [+4]

Any pathological disorder related to reproductive system anatomy [+13]

Status: Recruiting

Autologous Platelet-Rich Plasma Intra-ovarian Infusion in Poor Responders

Autologous PRP intra ovarian infusion may improve ovarian response, patients' hormonal profile as well as fresh embryo transfer (ET)-ICSI cycles' outcome in patients presenting with Poor Ovarian Response (POR).

Participants needed: 100
Trial details
Phase: Phase 2, Phase 3Age: 35-47Biological sex: FemaleType: InterventionalSponsor: Genesis Athens ClinicUpdated: Dec 27, 2024Locations: 1
Eligibility criteria

Poor Ovarian Response according to Bologna Criteria (fulfilling 2 out of 3 of th... [+5]

Any pathological disorder related to reproductive system anatomy [+14]